Evidence map›Paper›PMID 7604016›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

A type 1 serine/threonine kinase receptor that can dorsalize mesoderm in Xenopus.

D Mahony, J B Gurdon

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

D MahonyWellcome/CRC Institute, Cambridge, United Kingdom.
J B Gurdon
University of Cambridge · GBWellcome Trust · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

We have cloned a type I serine/threonine kinase receptor, XTrR-I, from Xenopus. XTrR-I (Xenopus transforming growth factor beta-related receptor type I) is expressed in all regions of embryos throughout early development. Overexpression of this receptor does not affect ectoderm or endoderm but dorsalizes the mesoderm such that muscle appears in ventral mesoderm and notochord appears in lateral mesoderm normally fated to become muscle. In addition, overexpression of XTrR-I in UV-treated embryos is able to cause formation of a partial dorsal axis. These results suggest that XTrR-I encodes a receptor which responds in normal development to a transforming growth factor beta-like ligand so as to promote dorsalization. Its function would therefore be to direct mesodermalized tissue into muscle or notochord.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCloning, MolecularDNA PrimersEmbryonic and Fetal DevelopmentEmbryo, NonmammalianFemaleFertilizationGene ExpressionMaleMesodermMolecular Sequence DataPolymerase Chain ReactionProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaDNA PrimersProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaRNA, MessengerXTrR-I receptor

Identifiers

PMID7604016
PMCPMC41540
OpenAlexW1987314151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.